Dr Richard Steeds MA MD FRCP FESC

Dr Richard Steeds

Institute of Cardiovascular Sciences
Honorary Reader and Consultant in Cardiovascular Imaging

Contact details

Address
Institute of Cardiovascular Sciences
University of Birmingham
Edgbaston
Birmingham
B15 2TT
UK

Dr Steeds is Honorary Reader within the Institute of Cardiovascular Sciences at the University of Birmingham and Consultant Cardiologist in Cardiovascular Imaging at University Hospitals Birmingham. He is an international figure in cardiovascular imaging and is an NIHR Advanced Research Scholar. He was previously President of the British Society of Echocardiography, having been Chair of the Education Committee and on the Executive Committee of the British Society of Cardiology.

Dr Steeds is currently involved in development of an automated electronic stethoscope for the early detection of significant valvular heart disease, launched at the beginning of 2020 with £1.2 million funding from the MRC. In addition, he is leading research into cardiac arrhythmias in patients with rare cardiomyopathy, using cardiovascular magnetic resonance imaging, echocardiography and biomarkers to develop a risk stratification tool to prevent the high rate of major adverse cardiovascular events in Fabry disease, funded by £1 million investigator-led funding from commercial sources.

Dr Steeds publishes regularly in leading journals, including Journal of the American College of Cardiology, Heart and associated imaging journals, and lectures frequently at national and international meetings.

Qualifications

  • MA Law (University of Cambridge) 1985
  • MBBS (University of London) 1991
  • MD in Cardiovascular Sciences 2001
  • Fellow of the Royal College of Physicians (London) 2008
  • Fellow of the British Society of Echocardiography
  • Fellow of the European Society of Cardiology 2009

Biography

Richard Steeds is an Honorary Reader at the Institute of Cardiovascular Sciences, University of Birmingham, and a Consultant Cardiologist at University Hospitals Birmingham, United Kingdom specialising in the diagnosis, monitoring and treatment of valvular heart disease and in the management of cardiomyopathy, including rare and metabolic diseases. He is Clinical Lead for Cardiovascular Imaging, incorporating multimodality approaches using echocardiography, magnetic resonance and nuclear imaging.

His practice incorporates out-patient and in-patient management, using advanced echocardiography, cardio-pulmonary exercise stress testing and cardiovascular magnetic resonance imaging in the management of single and complex valve diseases

He is a past President of the British Society of Echocardiography, having previously been responsible for education with the Society at national level for more than 10 years and involved in the development of the BSE App. He has published more than 200 peer-reviewed research articles, and with funding from the BHF and commercial sources, he is currently using multiparametric CMR and echocardiography to investigate the role of myocardial infiltration in valvular heart disease and in cardiomyopathy related to rare diseases.

Teaching

  • MBChB
  • BMedSci
  • Clinical and Educational Supervisor Advanced Cardiovascular Imaging trainees

Dr Steeds makes substantial contributions to teaching both within the University of Birmingham and University Hospitals Birmingham and beyond. He was previously Chair of the Education Committee of the British Society of Echocardiography, developed a regional network of representatives delivering educational presentations in echocardiography across the United Kingdom and in the Republic of Ireland, as well as initiating national accreditation processes in stress echocardiography.

He is a lead for the Independent Assessment of Professional Skills within the National School of Healthcare Science, which is the final examination for HSST trainees, prior to becoming a Consultant Clinical Scientist.

Postgraduate supervision

Available for supervision

Subject areas

  • Diagnosis, progression and management of carcinoid heart disease
  • Screening and community detection and monitoring of valvular heart disease
  • Development of metabolic cardiomyopathies, including Fabry and Alstrom

Dr Steeds has been the primary or co-supervisor for 8 PhD students, who have all gone on to become either consultant cardiologists within the field of cardiovascular imaging and/or have developed independent research programmes within the University. He currently is supervising 3 PhD students, two of whom are researching arrhythmogenesis in Fabry cardiomyopathy and one who is examining the role of exercise and outcomes in arrhythmogenic right ventricular cardiomyopathy.

Research

Research Activity

Dr Steeds has a research programme focussed around the early detection, measurement of severity and optimal management of valvular heart disease. His current research includes investigation into the role of an ‘intelligent stethoscope’ in early detection, comparative studies of the accuracy of echocardiography and cardiovascular magnetic resonance imaging in the quantification of regurgitant valve lesions, and collaboration in a number of BHF-funded national and international studies investigating early intervention in asymptomatic disease.

Additional research is directed at the risk factors and development of arrhythmia in rare metabolic cardiomyopathies, using detection with implantable loop recorders and imaging to risk stratify individuals. A collaborative bench programme is starting to investigate automaticity in myocytes of patients affected by Fabry disease, and further projects in the development of restrictive cardiomyopathy in the ultra-rare Alstrom syndrome.

Dr Steeds is a group leader of the Birmingham Cardio –Renal Group with Professor Jonathan Townend and Professor Charles Ferro, whose broad theme of work is to characterise the structural and functional deterioration within the heart and arterial tree affecting patients with chronic kidney disease.

Research Groups and Centres

Birmingham Cardio –Renal Group 

Other activities

Consultant Cardiologist at University Hospitals Birmingham, United Kingdom since 2003, specialising in the diagnosis, monitoring and treatment of valvular heart disease and in the management of cardiomyopathy, including rare and metabolic diseases. He is Clinical Lead for Cardiovascular Imaging, incorporating multimodality approaches using echocardiography, magnetic resonance and nuclear imaging.

Publications

ORCHID ID: 0000-0001-5687-2535

Moody WE, Liu B, Mahmoud-Elsayed HM, Senior J, Lalla SS, Khan-Kheil AM, Brown S, Saif A, Moss A, Bradlow WM, Khoo J, Ahamed M, McAloon C, Hothi SS, Steeds RP (2021) Persisting Adverse Ventricular Remodeling in COVID-19 Survivors: A Longitudinal Echocardiographic Study. J Am Soc Echocardiogr. May;34(5):562-566. doi: 10.1016/j.echo.2021.01.020.

Sharma H, Liu B, Mahmoud-Elsayed H, Myerson SG, Steeds RP (2021). Multimodality Imaging in Secondary Mitral Regurgitation. Front Cardiovasc Med. 2020 Dec 22;7:546279. doi: 10.3389/fcvm.2020.546279.

Bunting KV, Gill SK, Sitch A, Mehta S, O'Connor K, Lip GY, Kirchhof P, Strauss VY, Rahimi K, Camm AJ, Stanbury M, Griffith M, Townend JN, Gkoutos GV, Karwath A, Steeds RP, Kotecha D (2021) Improving the diagnosis of heart failure in patients with atrial fibrillation. Heart. Jun;107(11):902-908. doi: 10.1136/heartjnl-2020-318557.

Kotecha D, Bunting KV, Gill SK, Mehta S, Stanbury M, Jones JC, Haynes S, Calvert MJ, Deeks JJ, Steeds RP, Strauss VY, Rahimi K, Camm AJ, Griffith M, Lip GYH, Townend JN, and Kirchhof P (2020) Effect of Digoxin vs Bisoprolol for Heart Rate Control in Atrial Fibrillation on Patient-Reported Quality of Life: The RATE-AF Randomized Clinical Trial. JAMA. Dec 22;324(24):2497-2508. doi: 10.1001/jama.2020.23138.

Liu B, Neil DAH, Premchand M, Bhabra M, Patel R, Barker T, Nikolaidis N, Billing JS, Treibel TA, Moon JC, González A, Hodson J, Edwards NC, and Steeds RP (2020) Myocardial fibrosis in asymptomatic and symptomatic chronic severe primary mitral regurgitation and relationship to tissue characterisation and left ventricular function on cardiovascular magnetic resonance. J Cardiovasc Magn Reson. Dec 14;22(1):86. doi: 10.1186/s12968-020-00674-4

Baig S, Dowd R, Edwards NC, Hodson J, Fabritz L, Vijapurapu R, Liu B, Geberhiwot T, Steeds RP (2020). Prospective cardiovascular magnetic resonance imaging in adults with Alström syndrome: silent progression of diffuse interstitial fibrosis. Orphanet J Rare Dis. Jun 5;15(1):139. doi: 10.1186/s13023-020-01426-4

Mahmoud-Elsayed HM, Moody WE, Bradlow WM, Khan-Kheil AM, Senior J, Hudsmith LE, Steeds RP (2020) Echocardiographic Findings in Patients With COVID-19 Pneumonia. Can J Cardiol. Aug;36(8):1203-1207. doi: 10.1016/j.cjca.2020.05.030.

Moody WE, Holloway B, Arumugam P, Gill S, Wahid YS, Boivin CM, Thomson LE, Berman DS, Armstrong MJ, Ferguson J, Steeds RP (2020) Prognostic value of coronary risk factors, exercise capacity and single photon emission computed tomography in liver transplantation candidates: A 5-year follow-up study. J Nucl Cardiol. May 11. doi: 10.1007/s12350-020-02126-z.

Vijapurapu R, Baig S, Nordin S, Augusto JB, Price AM, Wheeldon N, Lewis N, Kozor R, Kotecha D, Hodson J, Hughes DA, Moon JC, Geberhiwot T, Steeds RP (2020) Longitudinal Assessment of Cardiac Involvement in Fabry Disease Using Cardiovascular Magnetic Resonance Imaging. JACC Cardiovasc Imaging. Aug;13(8):1850-1852. doi: 10.1016/j.jcmg.2020.03.004.

Steeds RP, Myerson SG (2020) Imaging assessment of mitral and aortic regurgitation: current state of the art. Heart  Nov;106(22):1769-1776. doi: 10.1136/heartjnl-2019-316216.

Culture and collections

Schools, institutes and departments

Services and facilities